- Report
- July 2024
- 145 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2024
- 150 Pages
Global
From €4516EUR$4,750USD£3,794GBP
The Healthcare CDMO market is a subset of the larger Healthcare Services industry. It is comprised of Contract Development and Manufacturing Organizations (CDMOs) that provide services to the pharmaceutical and biotechnology industries. These services include drug development, clinical trial management, manufacturing, packaging, and distribution. CDMOs are responsible for the development and production of drugs, biologics, and medical devices, as well as the delivery of these products to the end user.
CDMOs are an integral part of the healthcare industry, providing a range of services that enable the development and delivery of safe and effective treatments. They are also responsible for ensuring that products meet regulatory requirements and are of the highest quality.
Some of the companies in the Healthcare CDMO market include Patheon, Catalent, Recipharm, Aenova, and Vetter. Show Less Read more
